[This Week's IPO] Demand Forecast and Subscription Schedule for the Third Week of May

In the third week of this month (May), Kistron and Linksolution will conduct demand forecasts for institutional investors. Intocell is preparing for its public subscription for retail investors.

<Demand Forecast>

◆Kistron= Kistron, an affiliate of the Koryo Steel Group, is engaged in the production of premium lead wire for lead wire and cable applications, as well as in solar power generation and leasing businesses. Premium lead wire is used to manufacture lead wire components for capacitors, which are inserted into the PCBs of electronic devices. Wire for cables is supplied to and used in infrastructure industries such as construction, civil engineering, plants, and power plants.

The number of shares to be offered is 6.3 million, with the desired offering price band set at 3,100 to 3,600 KRW per share. Through this offering, the company aims to raise between 19.5 billion and 22.6 billion KRW. The demand forecast for institutional investors will take place from May 12 to 16, followed by the public subscription for retail investors on May 22 and 23. Shinhan Investment Corp. is the lead underwriter.

◆Linksolution= Established in 2015, Linksolution is a 3D printing company that not only develops and sells 3D printer equipment but also provides differentiated one-stop solutions, including customized 3D printing services. The company contributes to the transformation of traditional manufacturing methods into smart automated manufacturing by leveraging high-precision, high-speed printing technology and a platform with excellent material compatibility.

The company plans to offer a total of 900,000 shares. The expected offering price is between 20,000 and 23,000 KRW per share. The demand forecast will be conducted over five days from May 16 to 22, and the public subscription for retail investors will be held on May 27 and 28. The company aims to be listed on KOSDAQ within the year. Shinyoung Securities is the lead underwriter.

<Public Subscription>

◆Intocell= The desired offering price per share is between 12,500 and 17,000 KRW. The demand forecast was completed by May 8, and the public subscription for retail investors is scheduled for May 13 and 14. Mirae Asset Securities is the lead underwriter.

Intocell is a company specializing in ADC platform research and development. It was founded by Park Taegyo, who is also a co-founder of Ligachem Bio and played a leading role in inventing the core platform technology 'ConjuALL.' Over the past 10 years, the company has developed platform technologies such as Opas, PMT, and proprietary drugs with various mechanisms of action (MOA), and is now prepared to advance as a global bio company.